Total Funding
9
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Agennix is a biopharmaceutical firm focused on creating innovative therapies and is dedicated to clinical development programs.
About the Company
Agennix AG is a publicly listed biopharmaceutical firm focused on developing innovative therapies to address significant unmet medical needs, aiming to enhance both the duration and quality of life for patients with serious illnesses. The Company's leading program is talactoferrin, an oral targeted therapy that has shown efficacy in
randomized, double-blind, placebo-controlled Phase 2 trials for non-small cell lung cancer and severe sepsis.
